# 2025-02737: Lonza Tampa to Import Psychedelic Shrooms for Science

2025-02737, Importer of Controlled Substances Application: Lonza Tampa, LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-02-18, effective Registered bulk manufacturers and applicants may submit comments or objections, or file a written request for a hearing, on or before March 20, 2025.; PRIA reads it as touching household money (as of 2026-09-24).

- Canonical: https://policyrisk.com/federal-register/2025-02737
- As of: 2026-09-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-02737
- Title: Importer of Controlled Substances Application: Lonza Tampa, LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 9735
- Published: 2025-02-18
- Effective: Registered bulk manufacturers and applicants may submit comments or objections, or file a written request for a hearing, on or before March 20, 2025.
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-24

## In one line

Lonza Tampa to Import Psychedelic Shrooms for Science

## Summary

Lonza Tampa, LLC wants to become an official importer of psilocybin, a controlled substance. This means they’ll be allowed to bring this drug into the U.S. for research or medical use. People who make or use these drugs can share their thoughts or ask for a hearing by March 20, 2025.

## Abstract

Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Approval Would Allow Psilocybin Imports for Research: benefit, medium. Lonza Tampa, LLC applied on February 4, 2025 to be registered to import psilocybin (drug code 7437, Schedule I) as bulk active pharmaceutical ingredient and as finished dosage units for clinical trials, research, and analytical purposes. If approved, that registration would authorize Lonza Tampa to…
- Commercial Import of Finished Psilocybin Not Authorized: cost, medium. The notice states that authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms of psilocybin for commercial sale. That means this registration, if issued, would not permit importing finished psilocybin products for commercial retail…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-02737 on federalregister.gov](https://www.federalregister.gov/documents/2025/02/18/2025-02737/importer-of-controlled-substances-application-lonza-tampa-llc)
- [2025-02737 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-02-18/pdf/2025-02737.pdf)

## Related
- [Previous: 2025-02733, Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Ins…](https://policyrisk.com/federal-register/2025-02733)
- [Next: 2025-02738, Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.](https://policyrisk.com/federal-register/2025-02738)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-02737 (as of 2026-09-24).
